OSR Holdings Inc. has completed its acquisition of Woori IO, making the company a consolidated subsidiary and strengthening OSR Holdings’ position in medical devices and digital health, particularly in noninvasive glucose monitoring and wearable health technologies. In connection with the closing, legacy shareholders of Woori IO have agreed to a three-year equity alignment framework, exchanging their equity interests in OSR Holdings Co., Ltd. into NASDAQ-listed OSR Holdings common stock at a reference price of $10.00 per share. The company is also reviewing a potential combination of its two medical device subsidiaries, Woori IO and RMC, to form an integrated medical technology and distribution company, with the possibility of pursuing a standalone IPO in Korea in the future.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-007987), on January 27, 2026, and is solely responsible for the information contained therein.